| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000023709 |
| Receipt No. | R000027310 |
| Official scientific title of the study | Suppressive effect of test food on the postprandial blood glucose level -A randomized, double blind, placebo controlled, cross-over study- |
| Date of disclosure of the study information | 2016/08/23 |
| Last modified on | 2017/04/27 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Suppressive effect of test food on the postprandial blood glucose level -A randomized, double blind, placebo controlled, cross-over study- | |
| Title of the study (Brief title) | Suppressive effect of combination of test food on the postprandial blood glucose level | |
| Region |
|
|
| Condition | ||
| Condition | None | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the effect of test food on the postprandial blood glucose level of subjects. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Area under the curve for postprandial blood glucose level |
| Key secondary outcomes | Postprandial blood glucose levels and insulin levels of 30, 60, 90, and 120 minutes after rice ingestion. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake of test food, and then ingestion of placebo after wash out period. | |
| Interventions/Control_2 | Intake of placebo, and then ingestion of test food after wash out period. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Males and females 20 to 64 years of age
2) Subjects whose fasting blood glucose levels are less than 126 mg/dL. 3) Subjects whose Postprandial ingestion blood glucose levels on 30 minutes after rice 200g are more than 140 mg/dL and less than 200 mg/dL. |
|||
| Key exclusion criteria | 1) Subjects who routinely use medicine related to lipid metabolism.
2) Subjects whose HbA1c(NGSP) are more than 6.5% 3) Subjects who routinely use medicine, supplements, FOSHU, and/or health food which affect to result of the study. 4) Subjects who have allergy to test food and/or high fat meal and have extreme lactose intolerance or diarrhea. 5) Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating. 6) Heavy user of alcohol or excessive smokers 7) Subjects who have under treatment of chronic disease and routinely uses a medicine. |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Kazuhiko Takano |
| Organization | Medical Corporation Hokubukai Utsukushigaoka Hospital |
| Division name | clinical pharmacology center |
| Address | 61-1 Sin-ei, Kiyota-ku, Sapporo, Hokkaido 004-0839, Japan |
| TEL | 001-882-0111 |
| takano@ughp-cpc.jp | |
| Public contact | |
| Name of contact person | Masaya Tsubokawa |
| Organization | FANCL Corporation |
| Division name | Research Institute |
| Address | 12-13 Kamishinano, Totsuka-ku, Yokohama, Kanagawa, Japan |
| TEL | 045-820-3569 |
| Homepage URL | |
| tsubokawa_masaya@fancl.co.jp | |
| Sponsor | |
| Institute | FANCL Corporation |
| Institute | |
| Department | |
| Funding Source | |
| Organization | FANCL Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027310 |